BMJ 2017
To put that in perspective, semaglutide, which is currently one of the leading injectable weight loss medications in the world, produces average weight loss of around 14 to 15% over a similar time period
This class of medications contains the popular semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
Nevertheless, the precise neural pathways and signaling molecules involved still need to be further clarified, how PYY regulates the metabolism of the liver and skeletal muscles through the central nervous system, and how the intestinal microbiota participates in this process
Focusing on the effects of combination therapy on hyperandrogenism, Jensterle et al
Molecular Metabolism, 5 (9), 753758